Non-small cell lung carcinoma therapy using mTOR-siRNA

Molecular targeting agents play important roles in non-small-cell lung cancer (NSCLC) therapy. Published studies have investigated new drugs categorized as molecular targeting agents that inhibit the mammalian target of rapamycin (mTOR). We focused on a small interfering RNA (siRNA) that specificall...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Matsubara, Hirochika, Sakakibara, Kenji, Kunimitsu, Tamo, Matsuoka, Hiroyasu, Kato, Kaori, Oyachi, Noboru, Dobashi, Yoh, Matsumoto, Masahiko
Formato: Artigo
Idioma:Inglês
Publicado: e-Century Publishing Corporation 2012
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3294224/
https://ncbi.nlm.nih.gov/pubmed/22400071
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares